My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 190

    1.

    Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.

    Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS.

    Br J Ophthalmol. 2007 Feb;91(2):157-60. Epub 2006 Jul 26.PMID: 16870653 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

    Chan WM, Lai TY, Liu DT, Lam DS.

    Ophthalmology. 2007 Dec;114(12):2190-6. Epub 2007 Jun 28.PMID: 17599414 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia.

    Rhéaume MA, Sebag M.

    Can J Ophthalmol. 2008 Oct;43(5):576-80.PMID: 18982035 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.

    Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S.

    Br J Ophthalmol. 2009 Apr;93(4):448-51. Epub 2008 Dec 17.PMID: 19091851 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results.

    Arias L, Planas N, Prades S, Caminal JM, Rubio M, Pujol O, Roca G.

    Br J Ophthalmol. 2008 Aug;92(8):1035-9. Review.PMID: 18653595 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.

    Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, Oshima Y, Kusaka S, Tano Y.

    Br J Ophthalmol. 2007 Feb;91(2):161-5. Epub 2006 Aug 16.PMID: 16914470 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.

    Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB.

    Am J Ophthalmol. 2009 Jan;147(1):84-93.e1. Epub 2008 Sep 6.PMID: 18774547 [PubMed - indexed for MEDLINE]Related articles

    8.

    Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.

    Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y.

    Am J Ophthalmol. 2009 Oct;148(4):584-590.e2. Epub 2009 Jul 9.PMID: 19541288 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study.

    Chan WM, Lai TY, Liu DT, Lam DS.

    Br J Ophthalmol. 2009 Feb;93(2):150-4. Epub 2008 Sep 18.PMID: 18801766 [PubMed - indexed for MEDLINE]Related articles

    10.

    Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

    Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks.

    Wiegand TW, Rogers AH, McCabe F, Reichel E, Duker JS.

    Br J Ophthalmol. 2009 Jan;93(1):47-51. Epub 2008 Oct 29.PMID: 18971238 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularization.

    Adán A, Mateo C, Navarro R, Bitrian E, Casaroli-Marano RP.

    Retina. 2007 Nov-Dec;27(9):1180-6.PMID: 18046222 [PubMed - indexed for MEDLINE]Related articles

    14.

    Treatment of choroidal neovascularization using intravitreal bevacizumab.

    Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

    Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

    15.

    Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia.

    Hernández-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, Fromow-Guerra J, Amaya-Espinosa A, Solís-Vivanco A, Reyna-Castelán E, Abraham-Marín M, Martínez-Castellanos MA, Aiello LP.

    Retina. 2007 Jul-Aug;27(6):707-12.PMID: 17621179 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization.

    Mandal S, Venkatesh P, Sampangi R, Garg S.

    Eur J Ophthalmol. 2007 Jul-Aug;17(4):620-6.PMID: 17671940 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal bevacizumab in inflammatory ocular neovascularization.

    Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, Hrisomalos N, Lai TY, Dodwell D, Chan WM, Ness T, Banker AS, Pai SA, Berrocal MH, Tohme R, Heiligenhaus A, Bashshur ZF, Khairallah M, Salem KM, Hrisomalos FN, Wood MH, Heriot W, Adan A, Kumar A, Lim L, Hall A, Becker M.

    Am J Ophthalmol. 2008 Sep;146(3):410-416. Epub 2008 Jul 10.PMID: 18619571 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.

    Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, Tano Y.

    Am J Ophthalmol. 2009 Jan;147(1):94-100.e1. Epub 2008 Sep 6.PMID: 18774550 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.

    Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA.

    Retina. 2008 May;28(5):675-81.PMID: 18463509 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.

    Chan WM, Lai TY, Liu DT, Lam DS.

    Am J Ophthalmol. 2007 Jun;143(6):977-983. Epub 2007 Apr 24.PMID: 17459318 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity